Diego Aviles, MD
Pediatric Nephrology · New Orleans, LANPI 1538182548
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $14,000 of the $14,638 with a category attached, or 95.6%. Travere Therapeutics, Inc. accounts for 95.8% of it on its own, with 10 other manufacturers making up the rest. 2025 is the largest year on record at $5,320, more than ten times the $38 reported in 2019.
Across 24 payments — averaging $609.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Travere Therapeutics, Inc.$14K
- AstraZeneca$254
- Amgen$124
- Alnylam Pharmaceuticals Inc.$49
- Azurity Pharmaceuticals, Inc.$39
- Pfizer$35
- plus $110 from 5 others
What the payments were for
- Consulting fees$14,00096%
- Speaking & faculty fees$1501%
- Food & beverage$4883%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Travere Therapeutics, Inc. | 7 | $14,026 |
| AstraZeneca | 6 | $254 |
| Amgen | 1 | $124 |
| Alnylam Pharmaceuticals Inc. | 2 | $49 |
| Azurity Pharmaceuticals, Inc. | 2 | $39 |
| Pfizer | 1 | $35 |
| Eurofins Viracor, LLC | 1 | $32 |
| Apellis Pharmaceuticals, Inc. | 1 | $25 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| Grifols USA, LLC | 1 | $19 |
| Vantive US Healthcare LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few pediatric nephrology providers in Louisianato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sevelamer Carbonate | 14 | $1,619 |
| Calcitriol | 18 | $441 |
| Amlodipine Besylate | 29 | $161 |
| Prednisone | 27 | $154 |
Paid to pharmacies, not to this prescriber.
Other pediatric nephrology in New Orleans
- Samir El DahrNew Orleans$812
- Mohamad KhorkiNew Orleans$714
- Radhakrishna BaligaNew Orleans$368
- Kjoy SimmsNew Orleans$156
- Sarah ElhadiNew Orleans$19
- Ashley RawsonBaton Rouge$2K
- Amal EzzaiyaniBaton Rouge$227
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.